Free Trial
NASDAQ:XCUR

Exicure (XCUR) Stock Price, News & Analysis

Exicure logo
$18.38 +7.52 (+69.24%)
(As of 11/22/2024 ET)

About Exicure Stock (NASDAQ:XCUR)

Key Stats

Today's Range
$12.64
$19.62
50-Day Range
$2.21
$18.38
52-Week Range
$1.44
$19.62
Volume
4.29 million shs
Average Volume
1.57 million shs
Market Capitalization
$39.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Exicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Exicure Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
36th Percentile Overall Score

XCUR MarketRank™: 

Exicure scored higher than 36% of companies evaluated by MarketBeat, and ranked 730th out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Exicure.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Exicure is -8.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Exicure is -8.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Exicure has a P/B Ratio of 25.89. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Exicure's valuation and earnings.
  • Percentage of Shares Shorted

    4.71% of the float of Exicure has been sold short.
  • Short Interest Ratio / Days to Cover

    Exicure has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Exicure has recently increased by 72.78%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Exicure does not currently pay a dividend.

  • Dividend Growth

    Exicure does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.71% of the float of Exicure has been sold short.
  • Short Interest Ratio / Days to Cover

    Exicure has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Exicure has recently increased by 72.78%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Exicure has a news sentiment score of 0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Exicure this week, compared to 0 articles on an average week.
  • Search Interest

    7 people have searched for XCUR on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Exicure insiders have bought more of their company's stock than they have sold. Specifically, they have bought $711,669.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 3.90% of the stock of Exicure is held by insiders.

  • Percentage Held by Institutions

    42.82% of the stock of Exicure is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Exicure's insider trading history.
Receive XCUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exicure and its competitors with MarketBeat's FREE daily newsletter.

XCUR Stock News Headlines

XCUR/USD - Curate US Dollar
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
(PNGJL.BO)
Exicure, Inc. Receives Extension from Nasdaq Hearings Panel
What's Going On With Exicure Shares Monday?
See More Headlines

XCUR Stock Analysis - Frequently Asked Questions

Exicure's stock was trading at $0.5803 at the beginning of the year. Since then, XCUR stock has increased by 3,067.3% and is now trading at $18.38.
View the best growth stocks for 2024 here
.

Exicure, Inc. (NASDAQ:XCUR) announced its quarterly earnings data on Friday, November, 19th. The company reported ($40.50) EPS for the quarter, missing the consensus estimate of ($13.50) by $27.00. The company had revenue of ($3.68) million for the quarter, compared to analyst estimates of $0.80 million.

Exicure shares reverse split before market open on Tuesday, August 27th 2024. The 1-5 reverse split was announced on Monday, August 26th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 26th 2024. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Exicure's top institutional investors include Carlyle Group Inc. (3.26%) and Northwestern University (0.60%). Insiders that own company stock include Co Ltd Dgp, Cbi Usa, Inc and Gates Frontier, Llc.
View institutional ownership trends
.

Shares of XCUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Exicure investors own include Sorrento Therapeutics (SRNE), Allena Pharmaceuticals (ALNA), Tesla (TSLA), Meta Platforms (META), NIO (NIO), Viking Therapeutics (VKTX) and Energy Transfer (ET).

Company Calendar

Last Earnings
11/19/2021
Today
11/23/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
5/15/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:XCUR
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

Net Income
$-16,910,000.00
Pretax Margin
-799.80%

Debt

Sales & Book Value

Annual Sales
$28.83 million
Book Value
$0.71 per share

Miscellaneous

Free Float
2,087,000
Market Cap
$39.88 million
Optionable
Not Optionable
Beta
1.28
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:XCUR) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners